Unlabelled: Rett syndrome (RTT) is a neurodevelopmental disorder, which mainly affects females and results in multiple disabilities. Many clinical descriptions of the symptoms and functional abilities have been made medically, though mainly in children with RTT. Previous reports have established that even though the syndrome causes severe psychomotor disability, women with RTT can live long into adulthood.
Purpose: We aim to describe what to expect from aging women with RTT regarding some of the basic functional abilities that are used in daily activities and that could have an impact on quality of life in these women.
Methods: A team of two medical doctors, a physiotherapist and an educational psychological adviser, performed clinical evaluations of 27 women with RTT in Denmark above 30 years of age and confirmed MECP2 mutation.
Results: We found that 63% of the women were able to walk outside their homes and only 11% were not able to walk at all. However, 67% could not transfer from sitting to standing position without support. There was profound difficulties communicating, but 85.1% of the women could either consistently point with their hand or eyes to things of their interest.
Conclusions: Women with RTT are very dependent on caregivers who maintain and rehabilitate their functional abilities. They can often walk short distances unassisted, but do have trouble transferring and thus getting up from a chair on their own. They have severe problems communicating and they often perform subtle signs that can be difficult to recognize. Implications for rehabilitation 3/4 of aging RTT women are household ambulators - daily training of motor functions and focus on assisting the initiation of movements are needed lifelong to maintain walking ability and participation in daily activities More than half of aging women with RTT can grab on to things - persons with hand function should be motivated to use this ability in the context of eating Communication is a difficult task especially for the aging RTT women - Communicative signs, their meaning and how to react to them should be written down for every woman in an easy accessible way to all caregivers The majority of aging RTT women can point out things of interest - they should be given the opportunity to participate in choice making.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3109/09638288.2016.1170896 | DOI Listing |
Adv Ther
December 2024
Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, USA.
Introduction: Oral trofinetide administered using a body weight-banded dosing regimen was approved in the US for the treatment of Rett syndrome (RTT) in patients aged ≥ 2 years. This approval was principally based on efficacy and safety findings of the phase 3 LAVENDER study in girls and women aged 5-20 years with RTT and extended to younger children aged 2-4 years with supporting data from the DAFFODIL study. Weight-banded dosing regimens were selected based on early clinical population pharmacokinetic (popPK) modeling and different scenario simulations.
View Article and Find Full Text PDFEur J Ageing
December 2024
Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine, New York, NY, USA.
The Mobile Device Proficiency Questionnaire (MDPQ) is a well-established, reliable, and valid instrument to measure basic and advanced mobile device skills among older adults. We offer a German adaptation of the MDPQ and report reliability and validity findings. A controlled translation procedure was applied.
View Article and Find Full Text PDFJ Pediatr Gastroenterol Nutr
October 2024
Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
Biomedicines
September 2024
Institute for Advanced Co-Creation Studies, Osaka University, 1-3 Machikaneyama, Toyonaka 560-8531, Osaka, Japan.
Rett syndrome is a neurodevelopmental disorder that affects 1 in 10,000 females. Various treatments have been explored; however, no effective treatments have been reported to date, except for trofinetide, a synthetic analog of glycine-proline-glutamic acid, which was approved by the FDA in 2023. Serological biomarkers that correlate with the disease status of RTT are needed to promote early diagnosis and to develop novel agents.
View Article and Find Full Text PDFOrphanet J Rare Dis
August 2024
Anavex Life Sciences Corp, New York, NY, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!